Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Apoptosis. 2020 Oct;25(9-10):625–631. doi: 10.1007/s10495-020-01627-z

Figure 3. The role of BID in the combined treatment of ERA/ART and TRAIL-induced apoptosis.

Figure 3.

HCT116 WT or BID−/− cells were pretreated with ERA (50 μM) or artesunate (ART, 50 μM) for 20 h and then exposed to TRAIL (2 ng/ml) for an additional 4 h. Whole-cell lysates were analyzed with immunoblotting assay using indicated antibodies.